TRO19622

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Amyotrophic Lateral SclerosisNon-Alcoholic Steatohepatitis (NASH)

Phase 2

Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

CompletedNCT00666016

Hoffmann-La RocheNon-Alcoholic Steatohepatitis (NASH)

Start: 2008-04-15End: 2009-02-05Updated: 2025-12-18

Safety Extension Study of TRO19622 in ALS

CompletedNCT01285583

Hoffmann-La RocheAmyotrophic Lateral Sclerosis

Start: 2010-10-31End: 2012-03-31Updated: 2016-11-22